Literature DB >> 21763490

In vitro DNA tethering of HIV-1 integrase by the transcriptional coactivator LEDGF/p75.

Melissa McNeely1, Jelle Hendrix, Katrien Busschots, Eline Boons, Angélique Deleersnijder, Melanie Gerard, Frauke Christ, Zeger Debyser.   

Abstract

Although LEDGF/p75 is believed to act as a cellular cofactor of lentiviral integration by tethering integrase (IN) to chromatin, there is no good in vitro model to analyze this functionality. We designed an AlphaScreen assay to study how LEDGF/p75 modulates the interaction of human immunodeficiency virus type 1 IN with DNA. IN bound with similar affinity to DNA mimicking the long terminal repeat or to random DNA. While LEDGF/p75 bound DNA strongly, a mutant of LEDGF/p75 with compromised nuclear localization signal (NLS)/AT hook interacted weakly, and the LEDGF/p75 PWWP domain did not interact, corroborating previous reports on the role of NLS and AT hooks in charge-dependent DNA binding. LEDGF/p75 stimulated IN binding to DNA 10-fold to 30-fold. Stimulation of IN-DNA binding required a direct interaction between IN and the C-terminus of LEDGF/p75. Addition of either the C-terminus of LEDGF/p75 (amino acids 325-530) or LEDGF/p75 mutated in the NLS/AT hooks interfered with IN binding to DNA. Our results are consistent with an in vitro model of LEDGF/p75-mediated tethering of IN to DNA. The inhibition of IN-DNA interaction by the LEDGF/p75 C-terminus may provide a novel strategy for the inhibition of HIV IN activity and may explain the potent inhibition of HIV replication observed after the overexpression of C-terminal fragments in cell culture.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763490     DOI: 10.1016/j.jmb.2011.03.073

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  18 in total

1.  Small-molecule inhibitors of the LEDGF/p75 binding site of integrase block HIV replication and modulate integrase multimerization.

Authors:  Frauke Christ; Stephen Shaw; Jonas Demeulemeester; Belete A Desimmie; Arnaud Marchand; Scott Butler; Wim Smets; Patrick Chaltin; Mike Westby; Zeger Debyser; Chris Pickford
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  HIV Drug Resistance and the Advent of Integrase Inhibitors.

Authors:  Peter K Quashie; Thibault Mesplède; Mark A Wainberg
Journal:  Curr Infect Dis Rep       Date:  2013-02       Impact factor: 3.725

3.  Role of the PWWP domain of lens epithelium-derived growth factor (LEDGF)/p75 cofactor in lentiviral integration targeting.

Authors:  Rik Gijsbers; Sofie Vets; Jan De Rijck; Karen E Ocwieja; Keshet Ronen; Nirav Malani; Frederic D Bushman; Zeger Debyser
Journal:  J Biol Chem       Date:  2011-10-10       Impact factor: 5.157

4.  Lens epithelium-derived growth factor/p75 qualifies as a target for HIV gene therapy in the NSG mouse model.

Authors:  Sofie Vets; Janine Kimpel; Andreas Volk; Jan De Rijck; Rik Schrijvers; Bert Verbinnen; Wim Maes; Dorothee Von Laer; Zeger Debyser; Rik Gijsbers
Journal:  Mol Ther       Date:  2012-02-14       Impact factor: 11.454

5.  Interrogating HIV integrase for compounds that bind--a SAMPL challenge.

Authors:  Thomas S Peat; Olan Dolezal; Janet Newman; David Mobley; John J Deadman
Journal:  J Comput Aided Mol Des       Date:  2014-02-16       Impact factor: 3.686

6.  LEDGF/p75-independent HIV-1 replication demonstrates a role for HRP-2 and remains sensitive to inhibition by LEDGINs.

Authors:  Rik Schrijvers; Jan De Rijck; Jonas Demeulemeester; Noritaka Adachi; Sofie Vets; Keshet Ronen; Frauke Christ; Frederic D Bushman; Zeger Debyser; Rik Gijsbers
Journal:  PLoS Pathog       Date:  2012-03-01       Impact factor: 6.823

7.  Small molecule inhibitors of the LEDGF site of human immunodeficiency virus integrase identified by fragment screening and structure based design.

Authors:  Thomas S Peat; David I Rhodes; Nick Vandegraaff; Giang Le; Jessica A Smith; Lisa J Clark; Eric D Jones; Jonathan A V Coates; Neeranat Thienthong; Janet Newman; Olan Dolezal; Roger Mulder; John H Ryan; G Paul Savage; Craig L Francis; John J Deadman
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

Review 8.  Novel therapeutic strategies targeting HIV integrase.

Authors:  Peter K Quashie; Richard D Sloan; Mark A Wainberg
Journal:  BMC Med       Date:  2012-04-12       Impact factor: 8.775

9.  Structural basis for high-affinity binding of LEDGF PWWP to mononucleosomes.

Authors:  Jocelyn O Eidahl; Brandon L Crowe; Justin A North; Christopher J McKee; Nikoloz Shkriabai; Lei Feng; Matthew Plumb; Robert L Graham; Robert J Gorelick; Sonja Hess; Michael G Poirier; Mark P Foster; Mamuka Kvaratskhelia
Journal:  Nucleic Acids Res       Date:  2013-02-08       Impact factor: 16.971

10.  LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions.

Authors:  Belete Ayele Desimmie; Rik Schrijvers; Jonas Demeulemeester; Doortje Borrenberghs; Caroline Weydert; Wannes Thys; Sofie Vets; Barbara Van Remoortel; Johan Hofkens; Jan De Rijck; Jelle Hendrix; Norbert Bannert; Rik Gijsbers; Frauke Christ; Zeger Debyser
Journal:  Retrovirology       Date:  2013-05-30       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.